These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
591 related items for PubMed ID: 20228846
1. Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming. Zhao F, Mancuso A, Bui TV, Tong X, Gruber JJ, Swider CR, Sanchez PV, Lum JJ, Sayed N, Melo JV, Perl AE, Carroll M, Tuttle SW, Thompson CB. Oncogene; 2010 May 20; 29(20):2962-72. PubMed ID: 20228846 [Abstract] [Full Text] [Related]
2. Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate. Giuntoli S, Tanturli M, Di Gesualdo F, Barbetti V, Rovida E, Dello Sbarba P. Haematologica; 2011 Feb 20; 96(2):204-12. PubMed ID: 21071498 [Abstract] [Full Text] [Related]
5. Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation. Shi X, Chen X, Li X, Lan X, Zhao C, Liu S, Huang H, Liu N, Liao S, Song W, Zhou P, Wang S, Xu L, Wang X, Dou QP, Liu J. Clin Cancer Res; 2014 Jan 01; 20(1):151-63. PubMed ID: 24334603 [Abstract] [Full Text] [Related]
14. Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells. Fiskus W, Pranpat M, Balasis M, Bali P, Estrella V, Kumaraswamy S, Rao R, Rocha K, Herger B, Lee F, Richon V, Bhalla K. Clin Cancer Res; 2006 Oct 01; 12(19):5869-78. PubMed ID: 17020995 [Abstract] [Full Text] [Related]
15. Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells. Kominsky DJ, Klawitter J, Brown JL, Boros LG, Melo JV, Eckhardt SG, Serkova NJ. Clin Cancer Res; 2009 May 15; 15(10):3442-50. PubMed ID: 19401345 [Abstract] [Full Text] [Related]
16. Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells. Baran Y, Ural AU, Gunduz U. Hematology; 2007 Dec 15; 12(6):497-503. PubMed ID: 17852433 [Abstract] [Full Text] [Related]
17. [Research advance on molecular genetics of CML blast crisis]. Zhu HQ, Zhang S, Liu XL. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb 15; 16(1):217-21. PubMed ID: 18315935 [Abstract] [Full Text] [Related]
18. Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells. Bartholomeusz GA, Talpaz M, Kapuria V, Kong LY, Wang S, Estrov Z, Priebe W, Wu J, Donato NJ. Blood; 2007 Apr 15; 109(8):3470-8. PubMed ID: 17202319 [Abstract] [Full Text] [Related]